Renal amyloidosis and angioimmunoblastic lymphadenopathy.
Lim
A K
AK
Department of Nephrology, Queen Elizabeth Hospital, Birmingham, UK.
Ferreira
M A
MA
Majumdar
A
A
Wheeler
D C
DC
Lipkin
G W
GW
D000328:Adult; D000686:Amyloidosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000150:complications* / Q000473:pathology; D007674:Kidney Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone